BLUELINX HOLDINGS INC (BXC) Fundamental Analysis & Valuation
NYSE:BXC • US09624H2085
Current stock price
50.71 USD
+1.34 (+2.71%)
At close:
50.71 USD
0 (0%)
After Hours:
This BXC fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. BXC Profitability Analysis
1.1 Basic Checks
- BXC had positive earnings in the past year.
- In the past year BXC had a positive cash flow from operations.
- BXC had positive earnings in each of the past 5 years.
- Each year in the past 5 years BXC had a positive operating cash flow.
1.2 Ratios
- The Return On Assets of BXC (0.01%) is worse than 63.83% of its industry peers.
- The Return On Equity of BXC (0.04%) is worse than 65.96% of its industry peers.
- The Return On Invested Capital of BXC (1.69%) is worse than 68.09% of its industry peers.
- Measured over the past 3 years, the Average Return On Invested Capital for BXC is below the industry average of 9.20%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.01% | ||
| ROE | 0.04% | ||
| ROIC | 1.69% |
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
1.3 Margins
- With a Profit Margin value of 0.01%, BXC is not doing good in the industry: 65.96% of the companies in the same industry are doing better.
- BXC's Profit Margin has declined in the last couple of years.
- The Operating Margin of BXC (1.02%) is worse than 70.21% of its industry peers.
- BXC's Operating Margin has declined in the last couple of years.
- BXC's Gross Margin of 15.29% is on the low side compared to the rest of the industry. BXC is outperformed by 85.11% of its industry peers.
- In the last couple of years the Gross Margin of BXC has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 1.02% | ||
| PM (TTM) | 0.01% | ||
| GM | 15.29% |
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
2. BXC Health Analysis
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), BXC is destroying value.
- The number of shares outstanding for BXC has been reduced compared to 1 year ago.
- BXC has less shares outstanding than it did 5 years ago.
- BXC has a worse debt/assets ratio than last year.
2.2 Solvency
- BXC has an Altman-Z score of 3.29. This indicates that BXC is financially healthy and has little risk of bankruptcy at the moment.
- BXC has a Altman-Z score (3.29) which is comparable to the rest of the industry.
- BXC has a debt to FCF ratio of 18.81. This is a negative value and a sign of low solvency as BXC would need 18.81 years to pay back of all of its debts.
- Looking at the Debt to FCF ratio, with a value of 18.81, BXC is in line with its industry, outperforming 48.94% of the companies in the same industry.
- A Debt/Equity ratio of 0.96 indicates that BXC is somewhat dependend on debt financing.
- BXC has a worse Debt to Equity ratio (0.96) than 61.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 18.81 | ||
| Altman-Z | 3.29 |
ROIC/WACC0.19
WACC8.77%
2.3 Liquidity
- A Current Ratio of 4.66 indicates that BXC has no problem at all paying its short term obligations.
- With an excellent Current ratio value of 4.66, BXC belongs to the best of the industry, outperforming 95.74% of the companies in the same industry.
- BXC has a Quick Ratio of 3.12. This indicates that BXC is financially healthy and has no problem in meeting its short term obligations.
- BXC has a better Quick ratio (3.12) than 95.74% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 4.66 | ||
| Quick Ratio | 3.12 |
3. BXC Growth Analysis
3.1 Past
- The earnings per share for BXC have decreased strongly by -85.11% in the last year.
- Measured over the past years, BXC shows a very negative growth in Earnings Per Share. The EPS has been decreasing by -35.32% on average per year.
- Looking at the last year, BXC shows a small growth in Revenue. The Revenue has grown by 0.05% in the last year.
- Measured over the past years, BXC shows a decrease in Revenue. The Revenue has been decreasing by -0.94% on average per year.
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
3.2 Future
- BXC is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 85.45% yearly.
- The Revenue is expected to grow by 5.38% on average over the next years.
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. BXC Valuation Analysis
4.1 Price/Earnings Ratio
- Based on the Price/Earnings ratio of 53.38, the valuation of BXC can be described as expensive.
- Compared to the rest of the industry, the Price/Earnings ratio of BXC indicates a slightly more expensive valuation: BXC is more expensive than 65.96% of the companies listed in the same industry.
- Compared to an average S&P500 Price/Earnings ratio of 25.96, BXC is valued quite expensively.
- BXC is valuated quite expensively with a Price/Forward Earnings ratio of 90.87.
- 65.96% of the companies in the same industry are cheaper than BXC, based on the Price/Forward Earnings ratio.
- The average S&P500 Price/Forward Earnings ratio is at 24.04. BXC is valued rather expensively when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.38 | ||
| Fwd PE | 90.87 |
4.2 Price Multiples
- Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BXC indicates a somewhat cheap valuation: BXC is cheaper than 78.72% of the companies listed in the same industry.
- BXC's Price/Free Cash Flow ratio is rather cheap when compared to the industry. BXC is cheaper than 91.49% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 12.15 | ||
| EV/EBITDA | 8.87 |
4.3 Compensation for Growth
- A more expensive valuation may be justified as BXC's earnings are expected to grow with 85.45% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y85.45%
EPS Next 3YN/A
5. BXC Dividend Analysis
5.1 Amount
- No dividends for BXC!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
BXC Fundamentals: All Metrics, Ratios and Statistics
50.71
+1.34 (+2.71%)
Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCapital Goods
GICS IndustryTrading Companies & Distributors
Earnings (Last)02-24 2026-02-24/amc
Earnings (Next)04-27 2026-04-27
Inst Owners100.59%
Inst Owner Change1.59%
Ins Owners2.21%
Ins Owner Change0.01%
Market Cap399.09M
Revenue(TTM)2.95B
Net Income(TTM)219.00K
Analysts77.5
Price Target78.03 (53.87%)
Short Float %6.34%
Short Ratio5.05
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-16.66%
Min EPS beat(2)-23.18%
Max EPS beat(2)-10.14%
EPS beat(4)1
Avg EPS beat(4)-14.28%
Min EPS beat(4)-24.67%
Max EPS beat(4)0.88%
EPS beat(8)4
Avg EPS beat(8)9.11%
EPS beat(12)7
Avg EPS beat(12)11.85%
EPS beat(16)10
Avg EPS beat(16)12.41%
Revenue beat(2)1
Avg Revenue beat(2)-0.69%
Min Revenue beat(2)-2.07%
Max Revenue beat(2)0.69%
Revenue beat(4)1
Avg Revenue beat(4)-1.06%
Min Revenue beat(4)-2.07%
Max Revenue beat(4)0.69%
Revenue beat(8)3
Avg Revenue beat(8)-0.71%
Revenue beat(12)3
Avg Revenue beat(12)-2.91%
Revenue beat(16)5
Avg Revenue beat(16)-1.52%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)-98.67%
EPS NQ rev (3m)-108.39%
EPS NY rev (1m)-70.61%
EPS NY rev (3m)-71.45%
Revenue NQ rev (1m)1.94%
Revenue NQ rev (3m)1.64%
Revenue NY rev (1m)0.82%
Revenue NY rev (3m)0.68%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 53.38 | ||
| Fwd PE | 90.87 | ||
| P/S | 0.14 | ||
| P/FCF | 12.15 | ||
| P/OCF | 6.68 | ||
| P/B | 0.65 | ||
| P/tB | 0.86 | ||
| EV/EBITDA | 8.87 |
EPS(TTM)0.95
EY1.87%
EPS(NY)0.56
Fwd EY1.1%
FCF(TTM)4.17
FCFY8.23%
OCF(TTM)7.6
OCFY14.98%
SpS375.35
BVpS78.44
TBVpS58.88
PEG (NY)N/A
PEG (5Y)N/A
Graham Number40.95
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.01% | ||
| ROE | 0.04% | ||
| ROCE | 2.25% | ||
| ROIC | 1.69% | ||
| ROICexc | 2.37% | ||
| ROICexgc | 2.83% | ||
| OM | 1.02% | ||
| PM (TTM) | 0.01% | ||
| GM | 15.29% | ||
| FCFM | 1.11% |
ROA(3y)2.18%
ROA(5y)9.78%
ROE(3y)5.3%
ROE(5y)29.53%
ROIC(3y)4.86%
ROIC(5y)14.09%
ROICexc(3y)7.81%
ROICexc(5y)17.95%
ROICexgc(3y)8.79%
ROICexgc(5y)19.65%
ROCE(3y)6.47%
ROCE(5y)18.75%
ROICexgc growth 3Y-56.47%
ROICexgc growth 5Y-25.31%
ROICexc growth 3Y-57.61%
ROICexc growth 5Y-26.66%
OM growth 3Y-51.87%
OM growth 5Y-23.7%
PM growth 3Y-89.63%
PM growth 5Y-69.05%
GM growth 3Y-6.52%
GM growth 5Y-0.17%
F-Score5
Asset Turnover1.91
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 18.81 | ||
| Debt/EBITDA | 8.51 | ||
| Cap/Depr | 67.49% | ||
| Cap/Sales | 0.91% | ||
| Interest Coverage | 0.64 | ||
| Cash Conversion | 85.42% | ||
| Profit Quality | 15000.5% | ||
| Current Ratio | 4.66 | ||
| Quick Ratio | 3.12 | ||
| Altman-Z | 3.29 |
F-Score5
WACC8.77%
ROIC/WACC0.19
Cap/Depr(3y)85.86%
Cap/Depr(5y)87.75%
Cap/Sales(3y)1.05%
Cap/Sales(5y)0.86%
Profit Quality(3y)5219.88%
Profit Quality(5y)3165.36%
High Growth Momentum
Growth
EPS 1Y (TTM)-85.11%
EPS 3Y-68.55%
EPS 5Y-35.32%
EPS Q2Q%-177.05%
EPS Next Y-41.26%
EPS Next 2Y85.45%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.05%
Revenue growth 3Y-12.77%
Revenue growth 5Y-0.94%
Sales Q2Q%0.73%
Revenue Next Year3.9%
Revenue Next 2Y5.38%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-65.73%
EBIT growth 3Y-58.02%
EBIT growth 5Y-24.42%
EBIT Next Year80.11%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-27.11%
FCF growth 3Y-55.16%
FCF growth 5Y-8.53%
OCF growth 1Y-29.81%
OCF growth 3Y-46.94%
OCF growth 5Y1.68%
BLUELINX HOLDINGS INC / BXC Fundamental Analysis FAQ
What is the fundamental rating for BXC stock?
ChartMill assigns a fundamental rating of 4 / 10 to BXC.
What is the valuation status of BLUELINX HOLDINGS INC (BXC) stock?
ChartMill assigns a valuation rating of 3 / 10 to BLUELINX HOLDINGS INC (BXC). This can be considered as Overvalued.
What is the profitability of BXC stock?
BLUELINX HOLDINGS INC (BXC) has a profitability rating of 2 / 10.
How financially healthy is BLUELINX HOLDINGS INC?
The financial health rating of BLUELINX HOLDINGS INC (BXC) is 6 / 10.